ArticleJournal of clinical medicine2026
Integrated Inflammatory, Thrombo-Inflammatory, Redox and Soluble IFNAR2 Profiling During Hospitalization for COVID-19: An Exploratory Observational Cohort Study.
Álvaro Martínez Mesa, Eva Cabrera César, María García-Fernandez, Pablo Zamorano-González, María Mercedes Segura Romero, Javier López García, Elisa Martín-Montañez, Óscar Fernández, Jose Luis Velasco Garrido
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Álvaro Martínez MesaServicio de Neumología, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Eva Cabrera CésarServicio de Neumología, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
María García-FernandezDepartamento de Fisiología Humana, Facultad de Medicina, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, 29010 Málaga, Spain.ORCID 0000-0002-6436-1361 Pablo Zamorano-GonzálezDepartamento de Fisiología Humana, Facultad de Medicina, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, 29010 Málaga, Spain.ORCID 0000-0002-9552-4258 María Mercedes Segura RomeroServicio de Neumología, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Javier López GarcíaServicio de Neumología, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Elisa Martín-MontañezDepartamento de Farmacología y Pediatría, Facultad de Medicina, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, 29010 Málaga, Spain.ORCID 0000-0002-3637-3285 Óscar FernándezDepartamento de Farmacología y Pediatría, Facultad de Medicina, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, 29010 Málaga, Spain.
Jose Luis Velasco GarridoServicio de Neumología, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Funding
Grupo de Investigación de Neumología FIMABIS-Fundación para la Investigación de Málaga en Biomedicina y Salud IBIMA Plataforma BIONANDPlan Andaluz de Investigación, Desarrollo e Innovación CTS-156Proyectos de Colaboración Público-Privada, Plan Estatal de Investigación Científica, Técnica y de Innovación 2021-2023 CPP2021-008512
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biomarkersCOVID-19cytokinesD-dimerferritinoxidative stressprognosissIFNAR2
Identifiers
PMID42739730
PMCPMC13566477
What OpenQuestion holds
Textmetadata
Read underepoch 390